Medicinos vizija - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 38,598 | -2,914 | 17,657 | 9,153 | 20,078 | 17,683 | 32,110 | 30,833 |
| Profit before tax | -177 | - | - | - | - | - | - | - |
| Net profit | -351 | -9,398 | -8,605 | -8,201 | -342 | -704 | -11,909 | -8,781 |
| Equity | 2,784 | -6,614 | -15,219 | -23,420 | -23,762 | -24,466 | -36,375 | -45,156 |
| Liabilities | 40,352 | 31,568 | 32,205 | 32,622 | 32,738 | 32,177 | 40,253 | 47,996 |
| Non-current assets | 23,189 | 6,320 | 5,418 | 4,215 | 3,012 | 2,048 | 1,104 | 162 |
| Current assets | 18,899 | 17,098 | 9,907 | 3,486 | 4,463 | 4,162 | 1,273 | 1,177 |
| Total assets | 42,088 | 23,418 | 15,325 | 7,701 | 7,475 | 6,210 | 2,377 | 1,339 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 4,367 | 5,473 | 10,174 |
| Social insurance contributions | - | - | - | - | - | 2,578 | 3,611 | 2,215 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +67.4% | - | - | -48.2% | +119.4% | -11.9% | +81.6% | -4.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -0.8% | -40.1% | -56.2% | -106.5% | -4.6% | -11.3% | -501.0% | -655.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -12.6% | - | - | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -0.9% | - | -48.7% | -89.6% | -1.7% | -4.0% | -37.1% | -28.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -0.5% | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 14.5 | - | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 12,866 | - | 5,045 | 1,894 | 3,707 | 2,686 | 4,587 | 4,066 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Medicinos vizija - Social security debts
The amount of overdue SODRA debt for the company Medicinos vizija as of the last working day is: 1 €
| From | To | Debt, € |
|---|---|---|
| 2026-09-05 | 2026-09-13 | 0.54 |
| 2026-08-26 | 2026-09-02 | 0.54 |
| 2026-08-23 | 2026-08-23 | 0.54 |
| 2026-08-19 | 2026-08-19 | 0.54 |
| 2026-07-26 | 2026-07-26 | 317.98 |
| 2026-07-23 | 2026-07-25 | 318.64 |
| 2026-07-19 | 2026-07-22 | 317.98 |
| 2026-07-16 | 2026-07-17 | 317.98 |
| 2026-07-09 | 2026-07-09 | 10.65 |
| 2026-06-25 | 2026-07-08 | 13.33 |
| 2026-06-16 | 2026-06-24 | 188.51 |
| 2026-01-22 | 2026-01-26 | 4.60 |
| 2026-01-16 | 2026-01-21 | 4.53 |
| 2025-10-16 | 2025-10-21 | 39.79 |
| 2025-09-16 | 2025-09-17 | 16.02 |
| 2025-04-16 | 2025-04-16 | 116.01 |
| 2025-03-28 | 2025-03-30 | 35.83 |
| 2025-03-18 | 2025-03-27 | 179.91 |
| 2025-03-07 | 2025-03-12 | 54.69 |
| 2025-03-06 | 2025-03-06 | 63.32 |
| 2025-03-04 | 2025-03-05 | 75.78 |
| 2025-03-03 | 2025-03-03 | 118.70 |
| 2025-02-27 | 2025-03-02 | 103.93 |
| 2025-02-18 | 2025-02-26 | 118.70 |
| 2024-09-17 | 2024-09-29 | 233.68 |
| 2024-01-16 | 2024-01-28 | 0.33 |
| 2023-12-18 | 2023-12-27 | 0.33 |
| 2023-11-16 | 2023-12-11 | 0.33 |
| 2023-10-17 | 2023-11-07 | 0.33 |
| 2023-09-18 | 2023-10-10 | 0.33 |
| 2023-08-17 | 2023-09-11 | 0.33 |
| 2023-07-18 | 2023-08-08 | 0.33 |
| 2023-06-16 | 2023-07-09 | 0.33 |
| 2023-05-16 | 2023-06-11 | 0.33 |
| 2023-05-02 | 2023-05-11 | 0.33 |
| 2023-04-26 | 2023-04-28 | 0.33 |
| 2023-01-24 | 2023-01-31 | 73.47 |
| 2023-01-17 | 2023-01-23 | 72.75 |
| 2022-12-16 | 2022-12-28 | 98.22 |
| 2022-11-21 | 2022-12-05 | 49.12 |
| 2022-11-17 | 2022-11-18 | 49.12 |
| 2022-10-28 | 2022-11-07 | 0.20 |
| 2022-09-16 | 2022-09-28 | 47.98 |
Medicinos vizija - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Medicinos vizija is: 396 €
| From | To | Overdue, € |
|---|---|---|
| 2026-09-01 | 2026-09-02 | 396.15 |
| 2026-08-28 | 2026-08-31 | 394.06 |
| 2026-08-16 | 2026-08-27 | 237.06 |
| 2026-08-10 | 2026-08-15 | 183.42 |
| 2026-08-02 | 2026-08-09 | 183.02 |
| 2026-07-23 | 2026-08-01 | 182.57 |
| 2026-07-01 | 2026-07-22 | 390.3 |
| 2026-06-30 | 2026-06-30 | 389.3 |
| 2026-06-28 | 2026-06-29 | 389.26 |
| 2026-05-14 | 2026-05-17 | 79.63 |
| 2026-05-06 | 2026-05-13 | 0.62 |
| 2026-05-01 | 2026-05-05 | 72.79 |
| 2026-04-30 | 2026-04-30 | 72.38 |
| 2026-03-29 | 2026-04-01 | 48.46 |
| 2026-02-03 | 2026-02-03 | 22.04 |
| 2026-01-31 | 2026-02-02 | 19.94 |
| 2026-01-29 | 2026-01-30 | 19.0 |
| 2026-01-14 | 2026-01-20 | 419.28 |
| 2025-12-05 | 2025-12-09 | 0.05 |
| 2025-12-01 | 2025-12-04 | 21.78 |
| 2025-11-30 | 2025-11-30 | 21.76 |
| 2025-11-28 | 2025-11-29 | 21.73 |
| 2025-11-25 | 2025-11-25 | 79.47 |
| 2025-11-20 | 2025-11-24 | 179.47 |
| 2025-11-14 | 2025-11-19 | 358.59 |
| 2025-11-06 | 2025-11-09 | 270.35 |
| 2025-11-02 | 2025-11-05 | 710.16 |
| 2025-10-30 | 2025-11-01 | 677.81 |
| 2025-10-26 | 2025-10-29 | 439.81 |
| 2025-10-25 | 2025-10-25 | 596.16 |
| 2025-10-15 | 2025-10-21 | 118.7 |
| 2025-09-13 | 2025-09-14 | 108.84 |
| 2025-08-19 | 2025-08-19 | 17.24 |
| 2025-08-13 | 2025-08-18 | 16.82 |
| 2025-07-11 | 2025-07-20 | 395.7 |
| 2025-07-06 | 2025-07-10 | 0.98 |
| 2025-07-03 | 2025-07-05 | 0.6 |
| 2025-07-01 | 2025-07-02 | 712.16 |
| 2025-06-28 | 2025-06-30 | 710.72 |
| 2025-06-19 | 2025-06-27 | 278.72 |
| 2025-06-14 | 2025-06-18 | 276.27 |
| 2025-06-09 | 2025-06-10 | 70.67 |
| 2025-06-06 | 2025-06-08 | 210.7 |
| 2025-06-02 | 2025-06-05 | 210.4 |
| 2025-05-29 | 2025-06-01 | 209.26 |
| 2025-05-01 | 2025-05-13 | 5.09 |
| 2025-04-28 | 2025-04-30 | 4.43 |
| 2025-04-16 | 2025-04-17 | 156.16 |
| 2025-03-27 | 2025-03-27 | 4.89 |
| 2025-03-15 | 2025-03-26 | 0.03 |
| 2025-03-09 | 2025-03-14 | 1219.13 |
| 2025-03-08 | 2025-03-08 | 1314.58 |
| 2025-03-07 | 2025-03-07 | 1411.72 |
| 2025-03-04 | 2025-03-06 | 1689.61 |
| 2025-03-02 | 2025-03-03 | 2302.02 |
| 2025-02-28 | 2025-03-01 | 2282.51 |
| 2025-02-25 | 2025-02-27 | 2581.96 |
| 2025-02-23 | 2025-02-24 | 2640.07 |
| 2025-02-21 | 2025-02-22 | 2698.18 |
| 2025-02-20 | 2025-02-20 | 2846.29 |
| 2025-02-19 | 2025-02-19 | 3184.4 |
| 2025-02-04 | 2025-02-18 | 3441.07 |
| 2025-02-03 | 2025-02-03 | 3440.54 |
| 2025-01-26 | 2025-01-29 | 3.93 |
| 2025-01-22 | 2025-01-25 | 3.53 |
| 2025-01-08 | 2025-01-21 | 568.63 |
| 2025-01-01 | 2025-01-07 | 530.44 |
| 2024-12-31 | 2024-12-31 | 526.3 |
| 2024-12-30 | 2024-12-30 | 526.0 |
| 2024-12-13 | 2024-12-20 | 492.33 |
| 2024-12-12 | 2024-12-12 | 246.63 |
| 2024-12-03 | 2024-12-11 | 554.91 |
| 2024-11-29 | 2024-12-02 | 554.61 |
| 2024-11-28 | 2024-11-28 | 552.0 |
| 2024-11-17 | 2024-11-18 | 89.89 |
| 2024-10-16 | 2024-10-16 | 604.26 |
| 2024-10-12 | 2024-10-15 | 201.26 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Medicinos vizija, UAB (code 304626531) is a Private Limited Liability Company engaged in medical specialists activities. In 2025, the company generated revenue of €30.8K, slightly below the €32.1K reported in 2024, but still well above the €17.7K recorded in 2023. Over the two-year period, revenue increased by 74.4%, although the latest year showed a 4.0% decline. Profitability remained weak throughout the period: the company posted losses of €704 in 2023, €11.9K in 2024 and €8.8K in 2025, with a 2025 net margin of -28.5%. The balance sheet remained under pressure, as equity deepened to -€45.2K at the end of 2025, while liabilities rose to €48.0K and total assets were only €1.3K. Asset turnover was very high relative to the small asset base, indicating intensive use of limited assets, and revenue per employee stood at €4.4K in 2025. Overall, the latest year shows modest revenue resilience, but continued losses and a weakened capital structure.